Coder as Editor: Code-driven Interpretable Molecular Optimization

Molecular optimization is a central task in drug discovery that requires precise structural reasoning and domain knowledge. While large language models (LLMs) have shown promise in generating high-level editing intentions in natural language, they often struggle to faithfully execute these modifications-particularly when operating on non-intuitive representations like SMILES. We introduce MECo, a framework that bridges reasoning and execution by translating editing actions into executable code. MECo reformulates molecular optimization for LLMs as a cascaded framework: generating human-interpretable editing intentions from a molecule and property goal, followed by translating those intentions into executable structural edits via code generation. Our approach achieves over 98% accuracy in reproducing held-out realistic edits derived from chemical reactions and target-specific compound pairs. On downstream optimization benchmarks spanning physicochemical properties and target activities, MECo substantially improves consistency by 38-86 percentage points to 90%+ and achieves higher success rates over SMILES-based baselines while preserving structural similarity. By aligning intention with execution, MECo enables consistent, controllable and interpretable molecular design, laying the foundation for high-fidelity feedback loops and collaborative human-AI workflows in drug discovery.

Leveraging AI Agents for Autonomous Networks: A Reference Architecture and Empirical Studies

The evolution toward Level 4 (L4) Autonomous Networks (AN) represents a strategic inflection point in telecommunications, where networks must transcend reactive automation to achieve genuine cognitive capabilities--fulfilling TM Forum's vision of self-configuring, self-healing, and self-optimizing systems that deliver zero-wait, zero-touch, and zero-fault services. This work bridges the gap between architectural theory and operational reality by implementing Joseph Sifakis's AN Agent reference architecture in a functional cognitive system, deploying coordinated proactive-reactive runtimes driven by hybrid knowledge representation. Through an empirical case study of a Radio Access Network (RAN) Link Adaptation (LA) Agent, we validate this framework's transformative potential: demonstrating sub-10 ms real-time control in 5G NR sub-6 GHz while achieving 6% higher downlink throughput than Outer Loop Link Adaptation (OLLA) algorithms and 67% Block Error Rate (BLER) reduction for ultra-reliable services through dynamic Modulation and Coding Scheme (MCS) optimization. These improvements confirm the architecture's viability in overcoming traditional autonomy barriers and advancing critical L4-enabling capabilities toward next-generation objectives.

BudgetThinker: Empowering Budget-aware LLM Reasoning with Control Tokens

Recent advancements in Large Language Models (LLMs) have leveraged increased test-time computation to enhance reasoning capabilities, a strategy that, while effective, incurs significant latency and resource costs, limiting their applicability in real-world time-constrained or cost-sensitive scenarios. This paper introduces BudgetThinker, a novel framework designed to empower LLMs with budget-aware reasoning, enabling precise control over the length of their thought processes. We propose a methodology that periodically inserts special control tokens during inference to continuously inform the model of its remaining token budget. This approach is coupled with a comprehensive two-stage training pipeline, beginning with Supervised Fine-Tuning (SFT) to familiarize the model with budget constraints, followed by a curriculum-based Reinforcement Learning (RL) phase that utilizes a length-aware reward function to optimize for both accuracy and budget adherence. We demonstrate that BudgetThinker significantly surpasses strong baselines in maintaining performance across a variety of reasoning budgets on challenging mathematical benchmarks. Our method provides a scalable and effective solution for developing efficient and controllable LLM reasoning, making advanced models more practical for deployment in resource-constrained and real-time environments.

InvRGB+L: Inverse Rendering of Complex Scenes with Unified Color and LiDAR Reflectance Modeling

We present InvRGB+L, a novel inverse rendering model that reconstructs large, relightable, and dynamic scenes from a single RGB+LiDAR sequence. Conventional inverse graphics methods rely primarily on RGB observations and use LiDAR mainly for geometric information, often resulting in suboptimal material estimates due to visible light interference. We find that LiDAR's intensity values-captured with active illumination in a different spectral range-offer complementary cues for robust material estimation under variable lighting. Inspired by this, InvRGB+L leverages LiDAR intensity cues to overcome challenges inherent in RGB-centric inverse graphics through two key innovations: (1) a novel physics-based LiDAR shading model and (2) RGB-LiDAR material consistency losses. The model produces novel-view RGB and LiDAR renderings of urban and indoor scenes and supports relighting, night simulations, and dynamic object insertions, achieving results that surpass current state-of-the-art methods in both scene-level urban inverse rendering and LiDAR simulation.

MemAgent: Reshaping Long-Context LLM with Multi-Conv RL-based Memory Agent

Despite improvements by length extrapolation, efficient attention and memory modules, handling infinitely long documents with linear complexity without performance degradation during extrapolation remains the ultimate challenge in long-text processing. We directly optimize for long-text tasks in an end-to-end fashion and introduce a novel agent workflow, MemAgent, which reads text in segments and updates the memory using an overwrite strategy. We extend the DAPO algorithm to facilitate training via independent-context multi-conversation generation. MemAgent has demonstrated superb long-context capabilities, being able to extrapolate from an 8K context trained on 32K text to a 3.5M QA task with performance loss < 5% and achieves 95%+ in 512K RULER test.

The Singapore Consensus on Global AI Safety Research Priorities

Rapidly improving AI capabilities and autonomy hold significant promise of transformation, but are also driving vigorous debate on how to ensure that AI is safe, i.e., trustworthy, reliable, and secure. Building a trusted ecosystem is therefore essential -- it helps people embrace AI with confidence and gives maximal space for innovation while avoiding backlash. The "2025 Singapore Conference on AI (SCAI): International Scientific Exchange on AI Safety" aimed to support research in this space by bringing together AI scientists across geographies to identify and synthesise research priorities in AI safety. This resulting report builds on the International AI Safety Report chaired by Yoshua Bengio and backed by 33 governments. By adopting a defence-in-depth model, this report organises AI safety research domains into three types: challenges with creating trustworthy AI systems (Development), challenges with evaluating their risks (Assessment), and challenges with monitoring and intervening after deployment (Control).

AANet: Virtual Screening under Structural Uncertainty via Alignment and Aggregation

Virtual screening (VS) is a critical component of modern drug discovery, yet most existing methods--whether physics-based or deep learning-based--are developed around holo protein structures with known ligand-bound pockets. Consequently, their performance degrades significantly on apo or predicted structures such as those from AlphaFold2, which are more representative of real-world early-stage drug discovery, where pocket information is often missing. In this paper, we introduce an alignment-and-aggregation framework to enable accurate virtual screening under structural uncertainty. Our method comprises two core components: (1) a tri-modal contrastive learning module that aligns representations of the ligand, the holo pocket, and cavities detected from structures, thereby enhancing robustness to pocket localization error; and (2) a cross-attention based adapter for dynamically aggregating candidate binding sites, enabling the model to learn from activity data even without precise pocket annotations. We evaluated our method on a newly curated benchmark of apo structures, where it significantly outperforms state-of-the-art methods in blind apo setting, improving the early enrichment factor (EF1%) from 11.75 to 37.19. Notably, it also maintains strong performance on holo structures. These results demonstrate the promise of our approach in advancing first-in-class drug discovery, particularly in scenarios lacking experimentally resolved protein-ligand complexes.

PICD: Versatile Perceptual Image Compression with Diffusion Rendering

Recently, perceptual image compression has achieved significant advancements, delivering high visual quality at low bitrates for natural images. However, for screen content, existing methods often produce noticeable artifacts when compressing text. To tackle this challenge, we propose versatile perceptual screen image compression with diffusion rendering (PICD), a codec that works well for both screen and natural images. More specifically, we propose a compression framework that encodes the text and image separately, and renders them into one image using diffusion model. For this diffusion rendering, we integrate conditional information into diffusion models at three distinct levels: 1). Domain level: We fine-tune the base diffusion model using text content prompts with screen content. 2). Adaptor level: We develop an efficient adaptor to control the diffusion model using compressed image and text as input. 3). Instance level: We apply instance-wise guidance to further enhance the decoding process. Empirically, our PICD surpasses existing perceptual codecs in terms of both text accuracy and perceptual quality. Additionally, without text conditions, our approach serves effectively as a perceptual codec for natural images.

Towards Harnessing the Collaborative Power of Large and Small Models for Domain Tasks

Large language models (LLMs) have demonstrated remarkable capabilities, but they require vast amounts of data and computational resources. In contrast, smaller models (SMs), while less powerful, can be more efficient and tailored to specific domains. In this position paper, we argue that taking a collaborative approach, where large and small models work synergistically, can accelerate the adaptation of LLMs to private domains and unlock new potential in AI. We explore various strategies for model collaboration and identify potential challenges and opportunities. Building upon this, we advocate for industry-driven research that prioritizes multi-objective benchmarks on real-world private datasets and applications.

PharmAgents: Building a Virtual Pharma with Large Language Model Agents

The discovery of novel small molecule drugs remains a critical scientific challenge with far-reaching implications for treating diseases and advancing human health. Traditional drug development--especially for small molecule therapeutics--is a highly complex, resource-intensive, and time-consuming process that requires multidisciplinary collaboration. Recent breakthroughs in artificial intelligence (AI), particularly the rise of large language models (LLMs), present a transformative opportunity to streamline and accelerate this process. In this paper, we introduce PharmAgents, a virtual pharmaceutical ecosystem driven by LLM-based multi-agent collaboration. PharmAgents simulates the full drug discovery workflow--from target discovery to preclinical evaluation--by integrating explainable, LLM-driven agents equipped with specialized machine learning models and computational tools. Through structured knowledge exchange and automated optimization, PharmAgents identifies potential therapeutic targets, discovers promising lead compounds, enhances binding affinity and key molecular properties, and performs in silico analyses of toxicity and synthetic feasibility. Additionally, the system supports interpretability, agent interaction, and self-evolvement, enabling it to refine future drug designs based on prior experience. By showcasing the potential of LLM-powered multi-agent systems in drug discovery, this work establishes a new paradigm for autonomous, explainable, and scalable pharmaceutical research, with future extensions toward comprehensive drug lifecycle management.